Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$1.47B |
| 2 |
TC Energy
TRP
|
+$1.44B |
| 3 |
Broadcom
AVGO
|
+$1.37B |
| 4 |
Alcon
ALC
|
+$1.22B |
| 5 |
UnitedHealth
UNH
|
+$1.02B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.86B |
| 2 |
Verizon
VZ
|
+$1.9B |
| 3 |
Booking.com
BKNG
|
+$1.47B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.44B |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.37% |
| 2 | Technology | 16.98% |
| 3 | Consumer Discretionary | 12.52% |
| 4 | Communication Services | 11.95% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Meta Platforms (Facebook)
META
$1.51T
| $14.1B | 4.46% |
72,830,973
+1,159,041
| +2% | +$212M |
|
2
Microsoft
MSFT
$3.71T
| $12.6B | 4.01% |
94,254,634
-3,539,026
| -4% | -$449M |
|
3
Netflix
NFLX
$309B
| $10.4B | 3.31% |
283,674,430
+17,204,930
| +6% | +$621M |
|
4
Abbott
ABT
$187B
| $9.82B | 3.12% |
116,789,353
+1,217,776
| +1% | +$95.9M |
|
|
5
AbbVie
ABBV
$435B
| $8.01B | 2.54% |
110,124,019
-36,384,326
| -25% | -$2.86B |
|
|
6
Broadcom
AVGO
$2.04T
| $7.81B | 2.48% |
271,257,130
+47,071,060
| +21% | +$1.37B |
|
7
Amazon
AMZN
$2.96T
| $7.77B | 2.47% |
82,108,060
-715,080
| -0.9% | -$66.6M |
|
8
Gilead Sciences
GILD
$165B
| $5.52B | 1.75% |
81,748,687
+3,562,752
| +5% | +$234M |
|
9
Amgen
AMGN
$222B
| $5.45B | 1.73% |
29,557,757
-3,836,745
| -11% | -$687M |
|
|
10
UnitedHealth
UNH
$370B
| $5.39B | 1.71% |
22,092,897
+4,229,363
| +24% | +$1.02B |
|
11
Alibaba
BABA
$308B
| $5.13B | 1.63% |
30,279,619
+2,330,848
| +8% | +$402M |
|
12
ExxonMobil
XOM
$634B
| $4.69B | 1.49% |
61,202,040
-1,222,151
| -2% | -$94.6M |
|
13
Mastercard
MA
$493B
| $4.65B | 1.48% |
17,593,659
+254,293
| +1% | +$63.6M |
|
14
General Dynamics
GD
$106B
| $4.48B | 1.42% |
24,628,718
+1,523,817
| +7% | +$262M |
|
15
EOG Resources
EOG
$70.7B
| $4.45B | 1.41% |
47,731,164
+1,106,390
| +2% | +$103M |
|
16
Intel
INTC
$513B
| $4.2B | 1.33% |
87,686,990
-10,580,763
| -11% | -$525M |
|
|
17
Alphabet (Google) Class A
GOOGL
$4.33T
| $3.87B | 1.23% |
71,392,640
-16,295,900
| -19% | -$943M |
|
18
Thermo Fisher Scientific
TMO
$220B
| $3.78B | 1.2% |
12,860,635
-1,804,915
| -12% | -$497M |
|
|
19
Alphabet (Google) Class C
GOOG
$4.32T
| $3.58B | 1.14% |
66,285,940
-24,992,120
| -27% | -$1.44B |
|
20
CSX Corp
CSX
$93.1B
| $3.51B | 1.11% |
135,963,558
+5,706,786
| +4% | +$147M |
|
21
Home Depot
HD
$355B
| $3.49B | 1.11% |
16,771,494
+570,775
| +4% | +$114M |
|
22
Linde
LIN
$226B
| $3.25B | 1.03% |
16,199,695
+1,112,620
| +7% | +$208M |
|
23
Coca-Cola
KO
$375B
| $3.15B | 1% |
61,909,814
-4,751,919
| -7% | -$233M |
|
24
Nike
NKE
$61.9B
| $3.13B | 0.99% |
37,237,555
-4,263,209
| -10% | -$359M |
|
25
Accenture
ACN
$108B
| $3.09B | 0.98% |
16,705,812
-1,013,319
| -6% | -$182M |
|
Similar funds
Capital Research Global Investors's Q2 2019 Portfolio in Review
As of Q2 2019, Capital Research Global Investors held 443 positions worth $315B, down 0.14% from $315B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Capital Research Global Investors's Q2 2019 filing shows 29 new, 207 increased, 136 reduced and 42 closed positions. Its largest new stake was TC Energy: 30,064,463 shares worth $1.49B. The largest sale was AbbVie, an estimated $2.86B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
- Capital Research Global Investors's largest Q2 2019 buy was TC Energy: 30,064,463 shares worth $1.49B.
- Capital Research Global Investors added most to Constellation Brands in Q2 2019, an estimated $1.47B increase.
- Capital Research Global Investors's biggest Q2 2019 reduction was AbbVie, cutting an estimated $2.86B.
- Capital Research Global Investors fully exited Johnson Controls International in Q2 2019, selling an estimated $403M.
- Capital Research Global Investors's ten largest holdings make up 28% of its $315B portfolio in Q2 2019.
- Capital Research Global Investors opened 29 new positions and closed 42 in Q2 2019.
- Capital Research Global Investors's portfolio value fell 0.14% quarter-over-quarter to $315B.
Based on Capital Research Global Investors's 13F filing for Q2 2019, filed 14 Aug 2019.